1.
Nat Rev Drug Discov
; 16(12): 811-812, 2017 Dec.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29026211
RESUMEN
The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.